MCID: CMP058
MIFTS: 45

Complex Regional Pain Syndrome Type 1 malady

Categories: Neuronal diseases, Rare diseases

Aliases & Classifications for Complex Regional Pain Syndrome Type 1

About this section
Sources:
51Orphanet, 65UMLS, 28ICD10 via Orphanet
See all MalaCards sources

Aliases & Descriptions for Complex Regional Pain Syndrome Type 1:

Name: Complex Regional Pain Syndrome Type 1 51
Reflex Sympathetic Dystrophy 51 65
 
Algodystrophic Syndrome 65
Algodystrophy 51

Characteristics:

Orphanet epidemiological data:

51
reflex sympathetic dystrophy:
Age of onset: All ages

Classifications:



External Ids:

Orphanet51 99995
ICD10 via Orphanet28 M89.0
UMLS65 C1527353

Summaries for Complex Regional Pain Syndrome Type 1

About this section
MalaCards based summary: Complex Regional Pain Syndrome Type 1, also known as reflex sympathetic dystrophy, is related to complex regional pain syndrome and plantar nerve lesion, and has symptoms including chronic painand pain. An important gene associated with Complex Regional Pain Syndrome Type 1 is TNF (Tumor Necrosis Factor), and among its related pathways are African trypanosomiasis and IL-10 Pathway. Affiliated tissues include liver, bone and prostate.

Related Diseases for Complex Regional Pain Syndrome Type 1

About this section

Diseases in the Complex Regional Pain Syndrome family:

complex regional pain syndrome type 1

Diseases related to Complex Regional Pain Syndrome Type 1 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 139)
idRelated DiseaseScoreTop Affiliating Genes
1complex regional pain syndrome10.9
2plantar nerve lesion10.5IL6, TNF
3malignant sertoli-leydig cell tumor of ovary10.5IL6, TNF
4mammary paget's disease10.5IL6, TNF
5lujo hemorrhagic fever10.5IL6, TNF
6posterior valve urethra10.5IL6, TNF
7t cell immunodeficiency primary10.5IL6, TNF
8residual stage angle-closure glaucoma10.5IL6, TNF
9parovarian cyst10.5IL6, TNF
10precursor b lymphoblastic lymphoma/leukemia10.5IL6, TNF
11collagenous colitis10.5IL6, TNF
12paranoid schizophrenia10.5IL6, TNF
13ischemic optic neuropathy10.5IL6, TNF
14refractory plasma cell neoplasm10.5IL6, TNF
15early-onset, autosomal dominant alzheimer disease10.5IL6, TNF
16skin conditions10.5IL6, TNF
17tick-borne relapsing fever10.5IL6, TNF
18postsurgical hypothyroidism10.5IL6, TNF
19streptococcal meningitis10.5IL6, TNF
20hemorrhagic proctocolitis10.5IL6, TNF
21dancing eyes-dancing feet syndrome10.5IL6, TNF
22hemolytic anemia10.5IL6, TNF
23diffuse intraductal papillomatosis10.5IL6, TNF
24rubeosis iridis10.5IL6, TNF
25ureteral disease10.5IL6, TNF
26duodenum cancer10.5IL6, TNF
27idiopathic spinal cord herniation10.5IL6, TNF
28dentin caries10.5IL6, TNF
29placental abruption10.5IL6, TNF
30secretory diarrhea10.5IL6, TNF
31meige syndrome10.5IL6, TNF
32hypopharynx cancer10.5IL6, TNF
33vagus nerve neoplasm10.5IL6, TNF
34basilar artery occlusion10.5IL6, TNF
35submandibular gland disease10.4IL6, TNF
36cholera10.4IL6, TNF
37periodontal disease10.4IL6, TNF
38constant exophthalmos10.4IL6, TNF
39chagas disease10.4CALCA, TNF
40keratomalacia10.4IL6, TNF
41lateral sclerosis10.4IL6, TNF
42acute orbital inflammation10.4IL6, TNF
43acute zonal occult outer retinopathy10.4IL6, TNF
44bardet-biedl syndrome 810.4IL6, TNF
45villoglandular variant cervical mucinous adenocarcinoma10.4IL6, TNF
46trachoma10.4IL6, TNF
47acrodysostosis10.4IL6, TNF
48signet ring cell adenocarcinoma10.4IL6, TNF
49leech infestation10.4IL6, TNF
50conventional malignant hemangiopericytoma10.4IL6, TNF

Graphical network of the top 20 diseases related to Complex Regional Pain Syndrome Type 1:



Diseases related to complex regional pain syndrome type 1

Symptoms for Complex Regional Pain Syndrome Type 1

About this section

UMLS symptoms related to Complex Regional Pain Syndrome Type 1:


chronic pain, pain

Drugs & Therapeutics for Complex Regional Pain Syndrome Type 1

About this section

Drugs for Complex Regional Pain Syndrome Type 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 48)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Salmon Calcitoninapproved, investigationalPhase 45047931-85-116129616
Synonyms:
135506-95-5
47931-85-1
Astronin
Biocalcin
Bionocalcin
C028815
C06865
C145H239N43O48S2
CALCITONIN, SALMON
Cadens
Calciben
Calcihexal
Calcimar
Calcimar (TN)
Calcimonta
Calcinil
Calcioton
Calcitonin (Salmon Synthetic)
Calcitonin (salmon)
Calcitonin 1 precursor
Calcitonin Salmon
Calcitonin [USAN:INN:BAN:JAN]
Calcitonin salmon
Calcitonin salmon (USAN/INN)
Calcitonin salmon (synthesis)
Calcitonin salmon (synthesis) (JAN)
Calcitonin vom lachs
Calcitonin, salmar
Calcitonin, salmon
Calcitonin, salmon, for bioassay
Calcitonin,salmon
Calcitonin-salmon
Calcitonina
Calcitonine de saumon
Calcitoran
Calco
Calogen
Calsynar
Calsynar Lyo L
Caltine
Casalm
Catonin
Cibacalcin
Cibacalcine
Citonina
 
D00249
EINECS 256-342-8
Eptacalcin
Forcaltonin
Fortical
Fortical (TN)
Ipocalcin
Isi-calcin
Kalsimin
Karil
LS-48624
Miacalcic
Miacalcin
Miacalcin (TN)
Miracalcic
Oseototal
Osseocalcina
Osteobion
Osteovis
Ostosalm
Ostostabil
Porostenina
Prontocalcin
Quosten
Riostin
Rulicalcin
Salcat
Salcatonin
Salcatyn
Salmocalcin
Salmofar
Salmon calcitonin
Salmon calcitonin I
Salmon calcitonin-(I-32)
Salmotonin
Sical
Stalcin
Staporos
Steocin
TZ-CT
Thyrocalcitonin (salmon)
Tonocalcin
UNII-7SFC6U2VI5
Ucecal
recombinant salmon calcitonin
salmon calcitonin (1-32)
synthetic salmon calcitonin
2
Vitamin Capproved, nutraceuticalPhase 4, Phase 342450-81-75785, 54670067
Synonyms:
(+)-Sodium L-ascorbate
(+)-ascorbate
(+)-ascorbic acid
(2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one
(2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one
(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one
129940-97-2
134-03-2 (monosodium salt)
14536-17-5
154170-90-8
2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one
255564_SIAL
259133-78-3
3-Keto-L-gulofuranolactone
3-Oxo-L-gulofuranolactone
3-Oxo-L-gulofuranolactone (enol form)
30208-61-8
33034_RIEDEL
33034_SIAL
47863_SUPELCO
47A605F0-4187-47A8-B0CE-F9E7DA1B0076
50-81-7
50976-75-5
56172-55-5
56533-05-2
57304-74-2
57606-40-3
623158-95-2
6730-29-6
882690-91-7
884381-69-5
885512-24-3
88845-26-5
89924-69-6
95209_FLUKA
95209_SIGMA
95210_FLUKA
95210_SIAL
95212_FLUKA
A0278_SIGMA
A0537
A2174_SIGMA
A2218_SIGMA
A2343_SIGMA
A4403_SIGMA
A4544_SIGMA
A5960_SIGMA
A7506_SIGMA
A92902_ALDRICH
A92902_SIAL
AA
AB00376923
AB1002440
AC1L1L4T
AC1Q77S6
AR-1J3435
Acid Ascorbic
Acide ascorbique
Acide ascorbique [INN-French]
Acido ascorbico
Acido ascorbico [INN-Spanish]
Acidum ascorbicum
Acidum ascorbicum [INN-Latin]
Acidum ascorbinicum
Adenex
Allercorb
Ambap36431-82-0
Antiscorbic Vitamin
Antiscorbic vitamin
Antiscorbutic Vitamin
Antiscorbutic factor
Antiscorbutic vitamin
Arco-Cee
Arco-cee
Ascoltin
Ascoltin (TN)
Ascor-B.I.D.
Ascorb
Ascorbajen
Ascorbate
Ascorbic Acid
Ascorbic Acid, Monosodium Salt
Ascorbic acid
Ascorbic acid (JP15/USP/INN)
Ascorbic acid [BAN:INN:JAN]
Ascorbic acid [INN:BAN:JAN]
Ascorbicab
Ascorbicap
Ascorbicap (TN)
Ascorbicin
Ascorbin
Ascorbinsaeure
Ascorbutina
Ascorbyl radical
Ascorin
Ascorteal
Ascorvit
BPBio1_000363
BSPBio_000329
Babor Baborganic Biological Enzyme Cleanser
C-Level
C-Long
C-Quin
C-Span
C-Vimin
C00072
C6H8O6
CCRIS 57
CE-VI-Sol
CHEBI:29073
CHEMBL196
CID5785
Cantan
Cantaxin
Caswell No. 061B
Catavin C
Ce Lent
Ce lent
Ce-Mi-Lin
Ce-mi-lin
Ce-vi-sol
Cebicure
Cebid
Cebion
Cebione
Cecon
Cee-Caps TD
Cee-Caps Td
Cee-Vite
Cee-caps TD
Cee-vite
Cegiolan
Ceglion
Ceklin
Celaskon
Celin
Cell C
Cemagyl
Cemill
Cenetone
Cenolate
Cereon
Cergona
Cescorbat
Cetamid
Cetane
Cetane-Caps TC
Cetane-Caps TD
Cetane-Caps Tc
Cetane-Caps Td
Cetane-caps TC
Cetane-caps TD
Cetebe
 
Cetemican
Cevalin
Cevatine
Cevex
Cevi-Bid
Cevi-bid
Cevimin
Cevital
Cevitamate
Cevitamic Acid
Cevitamic acid
Cevitamin
Cevitan
Cevitex
Cewin
Chewcee
Ciamin
Cipca
Citriscorb
Citrovit
Colascor
Concemin
Cortalex
D00018
DB00126
Davitamon C
Dora-C-500
Duoscorb
EINECS 200-066-2
FEMA No. 2109
Ferancee
Ferrous ascorbate
HSDB 818
HiCee
Hicee
Hybrin
IDO-C
Ido-C
Iron(II) ascorbate
Iron-ascorbic acid complexes
Juvamine
Kangbingfeng
Kyselina Askorbova
Kyselina askorbova
Kyselina askorbova [Czech]
L(+)-Ascorbate
L(+)-Ascorbic acid
L-(+)-Ascorbate
L-(+)-Ascorbic Acid
L-(+)-Ascorbic acid
L-(+)-ascorbic acid
L-3-Ketothreohexuronic acid lactone
L-3-ketothreohexuronic acid
L-Ascorbate
L-Ascorbic Acid
L-Ascorbic acid
L-Ascorbic acid, free radical form
L-Lyxoascorbate
L-Lyxoascorbic Acid
L-Lyxoascorbic acid
L-Threo-ascorbic acid
L-Threoascorbic acid
L-Xyloascorbate
L-Xyloascorbic Acid
L-Xyloascorbic acid
L-ascorbate
L-threo-Hex-2-enonic acid, gamma-lactone
L-threo-ascorbic acid
L-threo-hex-2-enono-1,4-lactone
LS-145
Laroscorbine
Lemascorb
Liqui-Cee
Liqui-cee
MLS002153776
Magnesium Ascorbicum
Magnorbin
Meri-C
Meri-c
MolPort-001-792-501
Monodehydroascorbic acid
NCGC00091517-01
NCGC00091517-02
NCGC00164357-01
NCI-C54808
NSC 33832
Natrascorb
Natrascorb injectable
Oral Vitamin C
Planavit C
Prestwick3_000325
Proscorbin
Redoxon
Ribena
Ronotec 100
Rontex 100
Roscorbic
Rovimix C
SMR001233160
Scorbacid
Scorbu C
Scorbu-C
Secorbate
Semidehydroascorbate
Sodascorbate
Sodium Ascorbate (Ascorbic Acid)
Stuartinic
Suncoat VC 40
Sunkist
Testascorbic
Tolfrinic
UNII-PQ6CK8PD0R
VASC
Vicelat
Vicin
Vicomin C
Viforcit
Viscorin
Viscorin 100M
Vitace
Vitacee
Vitacimin
Vitacin
Vitamin C
Vitamin- C
Vitamin-?C
Vitamisin
Vitascorbol
W210901_ALDRICH
Xitix
antiscorbic vita min
ascor-b.i.d
ascorbate
ascorbic acid
bmse000182
cee-caps td
cevibid
component of Cortalex
component of E and C-Level
component of Endoglobin Forte
component of Ferancee
e 300
e-300
e300
gamma-Lactone L-threo-Hex-2-enonate
gamma-Lactone L-threo-Hex-2-enonic acid
l-ascorbic acid
l-threo-hex-1-eofuranos-3-ulose
nchembio.174-comp5
nchembio.89-comp1
nchembio.92-comp2
nchembio821-comp9
roscorbi c
vitamin C
3calcitoninPhase 450
4Calcitonin Gene-Related PeptidePhase 450
5Bone Density Conservation AgentsPhase 4, Phase 3, Phase 22600
6Vasodilator AgentsPhase 4, Phase 22926
7VitaminsPhase 4, Phase 33857
8MicronutrientsPhase 4, Phase 33901
9AntioxidantsPhase 4, Phase 32442
10Protective AgentsPhase 4, Phase 35651
11Trace ElementsPhase 4, Phase 33900
12
Zoledronic acidPhase 3286118072-93-868740
Synonyms:
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid
(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid
(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid
(1-hydroxy-2-imidazol-1-yl-phosphonoethyl)phosphonic acid monohydrate
118072-93-8
2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid
2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
AC-1092
AC1L2ACJ
AC1Q6RN3
AKOS005145739
Aclasta
BIDD:GT0292
BIDD:PXR0134
Bio-0112
Bisphosphonate 3
C088658
CGP 42'446
CGP 42446
CGP 42446A
CGP-42'446
CGP-42446
CHEBI:46557
CHEMBL924
CID68740
D08689
 
DB00399
FT-0082657
HMS2089O09
I06-0710
KS-1132
LS-181815
MolPort-002-885-874
MolPort-003-850-890
NCGC00159521-02
NCGC00159521-03
NSC721517
Novartis brand of zoledronic acid
Reclast
Reclast (TN)
S00092
S1314_Selleck
UNII-70HZ18PH24
ZOL
Zoledronate
Zoledronic acid
Zoledronic acid (INN)
Zoledronic acid [USAN:INN]
Zometa
Zometa (Novartis)
Zometa (TN)
Zometa Concentrate
Zometa, Zomera, Aclasta and Reclast, Zoledronic Acid
[1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid)
13DiphosphonatesPhase 2, Phase 3381
14Rho(D) Immune GlobulinPhase 3206
15AntibodiesPhase 34477
16Immunologic FactorsPhase 3, Phase 218483
17Immunoglobulins, IntravenousPhase 3211
18ImmunoglobulinsPhase 34477
19
ClonidineapprovedPhase 21894205-90-72803
Synonyms:
1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- (9CI)
2,6-Dichloro-N-2-imidazolidinylidenebenzenamine
2,6-dichloro-N-(2-imidazolidinylidene)aniline
2,6-dichloro-N-2-imidazolidinylidenebenzenamide
2,6-dichloro-N-imidazolidin-2-ylideneaniline
2-((2,6-Dichlorophenyl)imino)imidazolidine
2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2)
2-(2,6-Dichloroanilino)-2-imidazoline
2-(2,6-Dichlorophenylamino)-2-imidazoline
2-(2,6-Dichlorophenylimino)imidazolidine
2-Imidazoline, 2-(2,6-dichloroanilino)- (7CI,8CI)
2-[(2,6-Dichlorophenyl)imino]imidazoline
2-[(2,6-dichlorophenyl)imino]-2-imidazoline
4205-90-7
4205-91-8 (mono-hydrochloride)
57066-25-8
734571A
AB00514634
AC1L1EI5
AC1Q3K6V
AKOS001595470
Adesipress
BIDD:GT0547
BPBio1_000040
BRD-K98530306-001-02-1
BRD-K98530306-003-05-0
BSPBio_000036
BSPBio_001588
BSPBio_002055
Bio1_000470
Bio1_000959
Bio1_001448
Bio2_000308
Bio2_000788
C9H9Cl2N3
CAS-4205-91-8
CATAPRES-TTS-1
CATAPRES-TTS-2
CATAPRES-TTS-3
CCRIS 7787
CHEBI:3757
CHEBI:46632
CHEMBL134
CID2803
Catapres
Catapres- TTS
Catapres-TTS
Catapresan
Catapressan
Catarpres
Catarpres-TTS
Catarpres-TTS (TN)
Catarpresan
Chlofazoline
Chlornidinum
Clofenil
Clonidin
Clonidina
Clonidina [INN-Spanish]
Clonidine
Clonidine (JAN/USAN/INN)
Clonidine HCl
Clonidine Hydrochloride
Clonidine Transdermal System
Clonidine [USAN:BAN:INN]
Clonidinhydrochlorid
Clonidinum
Clonidinum [INN-Latin]
Clonistada
Clopheline
D00281
DB00575
DB07566
DivK1c_000774
 
Dixarit
Duraclon
Duraclont
EINECS 224-119-4
Gemiton
HMS1361P10
HMS1791P10
HMS1989P10
HMS2089G11
HSDB 3040
Hemiton
IDI1_000774
IDI1_034058
Ipotensium
Isoglaucon
KBio1_000774
KBio2_000308
KBio2_001821
KBio2_002876
KBio2_004389
KBio2_005444
KBio2_006957
KBio3_000615
KBio3_000616
KBio3_001275
KBioGR_000308
KBioGR_001572
KBioSS_000308
KBioSS_001821
Kapvay
Klofelin
Klofenil
L000193
LS-79606
Lopac-C-7897
Lopac0_000268
M 5041T
M-5041T
MolPort-001-779-668
MolPort-005-932-374
N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
NCGC00015268-01
NCGC00015268-02
NCGC00015268-08
NCGC00024734-01
NCGC00024734-02
NCGC00024734-03
NCGC00024734-04
NCGC00024734-05
NCGC00179680-01
NINDS_000774
Nexiclon
Nexiclon Xr
Prestwick0_000248
Prestwick1_000248
Prestwick2_000248
Prestwick3_000248
SKF 34427
SPBio_001233
SPBio_002255
ST 155BS
ST-155-BS
ST-155BS
Spectrum2_001187
Spectrum3_000358
Spectrum4_000956
Spectrum5_000759
Spectrum_001341
T171
Tenso-Timelets
Tocris-0690
UNII-MN3L5RMN02
ZINC00896484
clonidine
nchembio.79-comp11
nchembio705-10
20
LenalidomideapprovedPhase 2674191732-72-6216326
Synonyms:
1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline
191732-72-6
3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione
3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
3-(7-Amino-3-oxo-1H-isoindol-2-yl)-piperidine-2,6-dione
3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
346670-73-3
443912-14-9
AC-914
AC1L50II
AKOS005146276
ALBB-015321
Bio-0168
C467567
CC 5013
CC-5013
CC-5013, Revlimid, Lenalidomide
CC5013
CDC 501
CDC-501
CDC-5013
CHEMBL848
CID216326
Celgene brand of lenalidomide
D04687
 
DB00480
EC-000.2340
ENMD-0997
I06-0831
IMID-1
IMID-5013
IMiD3
IMiD3 cpd
IMid-1
LS-184040
Lenalidomide
Lenalidomide (USAN/INN)
Lenalidomide [USAN]
MolPort-003-848-370
NCGC00167491-01
NSC747972
Revamid
Revimid
Revlimid
Revlimid (Celgene)
Revlimid (TN)
S1029_Selleck
STK639603
Thalidomide analog CC-5013
UNII-F0P408N6V4
lenalidomide
21
Adenosineapproved, investigationalPhase 236358-61-760961
Synonyms:
(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-D-Ribofuranose
1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-delta-Ribofuranose
1odi
2fqy
2gl0
30143-02-3
4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside
46946-45-6
46969-16-8
58-61-7
6-Amino-9-.beta.-ribofuranosyl-9H-purine
6-Amino-9-beta-D-ribofuranosyl-9H-purine
6-Amino-9beta-D-ribofuranosyl-9H-purine
6-Amino-9beta-delta-ribofuranosyl-9H-purine
9-(beta-D-Arabinofuranosyl)adenine
9-beta-D-Arabinofuranosyladenine
9-beta-D-Ribofuranosidoadenine
9-beta-D-Ribofuranosyl-9H-purin-6-amine
9-beta-D-Ribofuranosyladenine
9-beta-delta-Arabinofuranosyladenine
9-beta-delta-Ribofuranosidoadenine
9-beta-delta-Ribofuranosyl-9H-purin-6-amine
9-beta-delta-Ribofuranosyladenine
9beta-D-Ribofuranosyladenine
9beta-D-ribofuranosyl-9H-Purin-6-amine
9beta-delta-Ribofuranosyladenine
9beta-delta-ribofuranosyl-9H-Purin-6-amine
A0152
A4036_SIGMA
A9251_SIGMA
AC1L1U8O
AC1Q1ID3
AC1Q52XU
ADN
AI3-52413
Ade-Rib
Ade-rib
Adenin riboside
Adenine 9-beta-D-arabinofuranoside
Adenine deoxyribonucleoside
Adenine nucleoside
Adenine riboside
Adenine-9-beta-D-ribofuranoside
Adenine-9beta-D-Ribofuranoside
Adenine-9beta-delta-Ribofuranoside
Adenocard
Adenocard (TN)
Adenocard, Adenosine
Adenocor
Adenoscan
Adenoscan (TN)
Adenosin
Adenosin [German]
Adenosina
Adenosine
Adenosine (JAN/USP)
Adenosine [USAN:BAN]
Adenosine, homopolymer
Adenosinum
Adensoine
Adenyldeoxyriboside
Ado
Adénosine
BB_NC-0565
BSPBio_001796
Bio1_000437
 
Bio1_000926
Bio1_001415
Boniton
C00212
CCRIS 2557
CHEBI:16335
CHEMBL477
CID60961
Caswell No. 010B
D000241
D00045
DB00640
Deoxyadenosine
Desoxyadenosine
EA6C60C2-6AFB-4264-A2F0-541373DB950E
EINECS 200-389-9
FT-0082881
HMS1920A13
HMS2091G13
KBio3_001296
LS-15085
MEDR-640
MLS000069638
MLS002153227
MolPort-001-838-229
Myocol
NCGC00023673-03
NCGC00023673-04
NCGC00023673-05
NCGC00023673-06
NCGC00023673-07
NSC 627048
NSC 7652
NSC627048
NSC7652
Nucleocardyl
Pallacor
Polyadenosine
Polyriboadenosine
S1647_Selleck
SDCCGMLS-0003108.P003
SMR000058216
SPBio_001194
SPECTRUM1500107
SR 96225
SR-96225
SUN-Y4001
Sandesin
Spectrum2_001257
Spectrum3_000288
TL8003749
UNII-K72T3FS567
USAF CB-10
V0098
Vidarabine
ZINC02169830
adenine-D-ribose
adenosine
b-D-Adenosine
beta-Adenosine
beta-D-Adenosine
beta-D-Ribofuranoside, adenine-9
beta-delta-Adenosine
bmse000061
nchembio.143-comp9
nchembio.186-comp109
nchembio.2007.56-comp13
nchembio.64-comp4
nchembio706-5
22Antihypertensive AgentsPhase 23618
23Neurotransmitter AgentsPhase 214795
24Peripheral Nervous System AgentsPhase 218510
25Purinergic P1 Receptor AgonistsPhase 2131
26Adrenergic alpha-AgonistsPhase 21300
27Anti-Arrhythmia AgentsPhase 22371
28Adrenergic AgentsPhase 24204
29Adrenergic AgonistsPhase 22331
30AnalgesicsPhase 29358
31Adrenergic alpha-2 Receptor AgonistsPhase 2790
32AnticonvulsantsPhase 22249
33NeurotropinPhase 24
34Immunosuppressive AgentsPhase 210422
35Adjuvants, ImmunologicPhase 21783
36Anti-Infective AgentsPhase 217220
37Angiogenesis Modulating AgentsPhase 23611
38Angiogenesis InhibitorsPhase 23688
39Anti-Bacterial AgentsPhase 29140
40
Pregabalinapproved, illicit, investigational340148553-50-85486971
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3-Isobutyl gaba
3-isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
CI-1008
CID5486971
 
D02716
DB00230
FT-0080911
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregablin
S-(+)-3-isobutylgaba
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
41Anesthetics7385
42Central Nervous System Depressants10016
43Contraceptives, Oral3734
44Tranquilizing Agents3597
45Psychotropic Drugs5501
46Anti-Anxiety Agents1529
47Calcium, Dietary4678
48calcium channel blockers1743

Interventional clinical trials:

(show all 28)
idNameStatusNCT IDPhase
1Prophylactic Administration of Vitamin C in Wrist FracturesCompletedNCT00296868Phase 4
2Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal WomenCompletedNCT00239889Phase 4
3A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1CompletedNCT00166452Phase 3
4Pain Exposure Physical Therapy (PEPT) Versus CBO in Patients With Complex Regional Pain Syndrome Type I (CRPS-1)CompletedNCT00817128Phase 2, Phase 3
5A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1RecruitingNCT02504008Phase 3
6Efficacy and Safety of Intravenous Neridronic Acid in CRPS-IActive, not recruitingNCT02402530Phase 2, Phase 3
7Intravenous Immunoglobulins in Complex-regional Pain SyndromeNot yet recruitingNCT00949065Phase 3
8Role of Vitamin C at 6 Months on Incidence of Complex Regional Pain Syndrome Type I in Upper Limb SurgeryNot yet recruitingNCT02390505Phase 3
9A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)CompletedNCT00067743Phase 2
10Clonidine Versus Adenosine to Treat Neuropathic PainCompletedNCT00349921Phase 2
11Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1TerminatedNCT00109772Phase 2
12Neurotropin to Treat Chronic Neuropathic PainTerminatedNCT00006289Phase 2
13Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain.RecruitingNCT02321566Phase 1
14The Rubber Hand Illusion (RHI) in Patients With CRPSCompletedNCT01618578
15Graded Exposure (GEXP) in Vivo Versus Physiotherapy in Complex Regional Pain Syndrome Type I (CRPS-I)CompletedNCT00625976
16Near-infrared Spectroscopic Measurement in Complex Regional Pain SyndromeCompletedNCT01586377
17Correlation Between 3 Phase Bone Scintigraphy and Pressure Pain Thresholds in Patients With Complex Regional Pain Syndrome (CRPS)CompletedNCT01623141
18Effects of Repetitive Electric Sensory Stimulation (RSS) as Intervention in Complex-regional-pain-syndrome Type I (CRPS)RecruitingNCT01915329
19Neurophysiological Basis of Rehabilitation in Complex Regional Pain Syndrome, Type I and Chronic Low Back PainRecruitingNCT02347579
20Association of Transcutaneous Electrical Nerve Stimulation and HypnosisRecruitingNCT01944150
21Two Measures of Tactile Acuity in CRPS Type I PatientsRecruitingNCT01888783
22Multi-disciplinary Prevention ProgramRecruitingNCT02563431
23Investigation of the Efficacy of tDCS in the Treatment of Complex Regional Pain Syndrome (CRPS) Type 1Active, not recruitingNCT01960400
24Regional Anesthesia Military Battlefield Pain Outcomes StudyActive, not recruitingNCT00431847
25The Effect of Vitamin c on Preventing Complex Regional Pain Syndrome (CRPS Type I) Following Ankle FractureNot yet recruitingNCT01338129
26The Effect of Transcranial Direct Current Stimulation (t-DCS) On the P300 Component of Event-Related Potentials in Patients With Chronic Neuropathic Pain Due To CRPS or Diabetic NeuropathyNot yet recruitingNCT00815932
27Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study)TerminatedNCT00891397
28Single-port Thoracoscopic Sympathicotomy in Complex Regional Pain Syndrome Type I (CRPS)WithdrawnNCT01886625

Search NIH Clinical Center for Complex Regional Pain Syndrome Type 1

Genetic Tests for Complex Regional Pain Syndrome Type 1

About this section

Anatomical Context for Complex Regional Pain Syndrome Type 1

About this section

MalaCards organs/tissues related to Complex Regional Pain Syndrome Type 1:

33
Liver, Bone, Prostate, Skin, Spinal cord, Heart, Monocytes

Animal Models for Complex Regional Pain Syndrome Type 1 or affiliated genes

About this section

Publications for Complex Regional Pain Syndrome Type 1

About this section

Articles related to Complex Regional Pain Syndrome Type 1:

(show top 50)    (show all 106)
idTitleAuthorsYear
1
Effects of Mirror Therapy in Stroke Patients With Complex Regional Pain Syndrome Type 1: A Randomized Controlled Study. (26723854)
2016
2
Complex regional pain syndrome type 1: Analysis of 108 patients. (27132482)
2016
3
Do psychological factors influence recovery from complex regional pain syndrome type 1? A prospective study. (26133727)
2015
4
Amputation as an Unusual Treatment for Therapy-Resistant Complex Regional Pain Syndrome, Type 1. (26730230)
2015
5
Musculoskeletal Ultrasonography to Distinguish Muscle Changes in Complex Regional Pain Syndrome Type 1 from Those of Neuropathic Pain: An Observational Study. (26307219)
2015
6
The value of nerve blocks in the diagnoses and treatment of complex regional pain syndrome type 1: a series of 14 cases. (24953701)
2014
7
The outcome of complex regional pain syndrome type 1: a systematic review. (24530407)
2014
8
Successful management of complex regional pain syndrome type 1 using single injection interscalene brachial plexus block. (25422619)
2014
9
Are pain-related fears mediators for reducing disability and pain in patients with complex regional pain syndrome type 1? An explorative analysis on pain exposure physical therapy. (25919011)
2014
10
Reversal of complex regional pain syndrome type 2 and the subsequent management of complex regional pain syndrome type 1 occurring after corrective surgery for residual ulnar claw. (24506435)
2014
11
Concurrence of malignant peripheral nerve sheath tumor at the site of complex regional pain syndrome type 1 - a case report -. (23614078)
2013
12
Health-related quality of life in 975 patients with complex regional pain syndrome type 1. (24342465)
2013
13
The role of pain coping and kinesiophobia in patients with complex regional pain syndrome type 1 of the legs. (23739533)
2013
14
Pain relief is associated with improvement in motor function in complex regional pain syndrome type 1: secondary analysis of a placebo-controlled study on the effects of ketamine. (24075073)
2013
15
Successful reversal of complex regional pain syndrome type 1 of both upper extremities in five patients. (22776058)
2012
16
Concurrent peripheral pathologies and complex regional pain syndrome type 1 as contributors to acute post-stroke shoulder pain: a case report. (22592581)
2012
17
Predictors of pain relieving response to sympathetic blockade in complex regional pain syndrome type 1. (22143169)
2012
18
Is physiotherapy effective for children with complex regional pain syndrome type 1? (21677566)
2012
19
Hypothalamic-pituitary-adrenal axis function in patients with complex regional pain syndrome type 1. (22445364)
2012
20
The effectiveness and cost evaluation of pain exposure physical therapy and conventional therapy in patients with complex regional pain syndrome type 1. Rationale and design of a randomized controlled trial. (22515496)
2012
21
The association between psychological factors and the development of complex regional pain syndrome type 1 (CRPS1)--a prospective multicenter study. (21459637)
2011
22
Biopsychosocial complexity is correlated with psychiatric comorbidity but not with perceived pain in complex regional pain syndrome type 1 (algodystrophy) of the knee. (20851028)
2011
23
Evidence based guidelines for complex regional pain syndrome type 1. (20356382)
2010
24
Role of peripheral endothelin receptors in an animal model of complex regional pain syndrome type 1 (CRPS-I). (20675053)
2010
25
An observational study on the effect of S+-ketamine on chronic pain versus experimental acute pain in Complex Regional Pain Syndrome type 1 patients. (19540140)
2010
26
The first scintigraphic detection of tumor necrosis factor-alpha in patients with complex regional pain syndrome type 1. (19910617)
2010
27
Mirror therapy for chronic complex regional pain syndrome type 1 and stroke. (19657134)
2009
28
Complex regional pain syndrome type 1 may be associated with menstrual cycle disorders: a case-control study. (19942105)
2009
29
Somatosensory conflicts in complex regional pain syndrome type 1 and fibromyalgia syndrome. (19922737)
2009
30
Intravenous magnesium for complex regional pain syndrome type 1 (CRPS 1) patients: a pilot study. (19496957)
2009
31
The effect of sequel symptoms and signs of Complex Regional Pain Syndrome type 1 on upper extremity disability and quality of life. (18953539)
2009
32
IgE-mediated hypersensitivity: patients with complex regional pain syndrome type 1 (CRPS1) vs the Dutch population. A retrospective study. (18721169)
2009
33
Is there an association between psychological factors and the Complex Regional Pain Syndrome type 1 (CRPS1) in adults? A systematic review. (19573987)
2009
34
Tumor necrosis factor-alpha and interleukin-6 are not correlated with the characteristics of Complex Regional Pain Syndrome type 1 in 66 patients. (18055234)
2008
35
Using skin surface temperature to differentiate between complex regional pain syndrome type 1 patients after a fracture and control patients with various complaints after a fracture. (18165590)
2008
36
Increased plasma serotonin in complex regional pain syndrome type 1. (18499624)
2008
37
Increased plasma glutamate, glycine, and arginine levels in complex regional pain syndrome type 1. (18419723)
2008
38
Vasodilative effect of isosorbide dinitrate ointment in complex regional pain syndrome type 1. (18180642)
2008
39
Correlation between changes in regional cerebral blood flow and pain relief in complex regional pain syndrome type 1. (16714887)
2006
40
Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1. (17137491)
2006
41
Thermography imaging during static and controlled thermoregulation in complex regional pain syndrome type 1: diagnostic value and involvement of the central sympathetic system. (16689997)
2006
42
Physicians' assessments versus measured symptoms of complex regional pain syndrome type 1: presence and severity. (15818079)
2005
43
The fasciitis-panniculitis syndrome presenting as complex regional pain syndrome type 1: report of a case. (15722813)
2005
44
Bone loss in the contralateral asymptomatic hand in patients with complex regional pain syndrome type 1. (14691686)
2004
45
Presentation and treatment of complex regional pain syndrome type 1 in a 3 year old. (15277940)
2004
46
A controlled pilot study of the utility of mirror visual feedback in the treatment of complex regional pain syndrome (type 1). (12509620)
2003
47
Impact of upper limb complex regional pain syndrome type 1 on everyday life measured with a novel upper limb-activity monitor. (12507702)
2003
48
Intravenous regional blocks with guanethidine and prilocaine combined with physiotherapy: two children with complex regional pain syndrome, type 1. (12095024)
2002
49
Changes in regional cerebral blood flow in the thalamus after electroconvulsive therapy for patients with complex regional pain syndrome type 1 (preliminary case series). (12373706)
2002
50
Long-term outcome following sympathectomy for complex regional pain syndrome type 1 (RSD). (9268243)
1997

Variations for Complex Regional Pain Syndrome Type 1

About this section

Expression for genes affiliated with Complex Regional Pain Syndrome Type 1

About this section
Search GEO for disease gene expression data for Complex Regional Pain Syndrome Type 1.

Pathways for genes affiliated with Complex Regional Pain Syndrome Type 1

About this section

Pathways related to Complex Regional Pain Syndrome Type 1 according to GeneCards Suite gene sharing:

(show all 17)
idSuper pathwaysScoreTop Affiliating Genes
19.6IL6, TNF
29.6IL6, TNF
39.6IL6, TNF
49.6IL6, TNF
59.6IL6, TNF
69.6IL6, TNF
79.6IL6, TNF
89.6IL6, TNF
99.3CALCA, EDN1
109.1CXCL9, CXCR3
119.1CALCA, IL6, TNF
12
Show member pathways
9.1CXCL9, IL6, TNF
139.0EDN1, IL6, TNF
149.0EDN1, IL6, TNF
15
Show member pathways
8.3CXCL9, CXCR3, IL6, TNF
16
Show member pathways
7.6CXCL9, CXCR3, EDN1, IL6, TNF
17
Show member pathways
7.1CALCA, CXCL9, CXCR3, EDN1, IL6, TNF

GO Terms for genes affiliated with Complex Regional Pain Syndrome Type 1

About this section

Cellular components related to Complex Regional Pain Syndrome Type 1 according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.2CXCR3, IL6

Biological processes related to Complex Regional Pain Syndrome Type 1 according to GeneCards Suite gene sharing:

(show all 29)
idNameGO IDScoreTop Affiliating Genes
1epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.3IL6, TNF
2negative regulation of lipid storageGO:001088810.2IL6, TNF
3defense response to Gram-positive bacteriumGO:005083010.2IL6, TNF
4negative regulation of fat cell differentiationGO:004559910.1IL6, TNF
5response to glucocorticoidGO:005138410.1IL6, TNF
6positive regulation of sequence-specific DNA binding transcription factor activityGO:005109110.1IL6, TNF
7positive regulation of peptidyl-serine phosphorylationGO:003313810.1IL6, TNF
8positive regulation of protein kinase B signalingGO:005189710.1IL6, TNF
9response to yeastGO:000187810.0CALCA, IL6
10positive regulation of MAP kinase activityGO:004340610.0EDN1, TNF
11negative regulation of hormone secretionGO:004688810.0EDN1, IL6
12positive regulation of interleukin-6 productionGO:00327559.9IL6, TNF
13response to amino acidGO:00432009.9EDN1, IL6
14positive regulation of apoptotic processGO:00430659.9IL6, TNF
15cell growthGO:00160499.9EDN1, IL6
16defense response to Gram-negative bacteriumGO:00508299.9CALCA, IL6
17monocyte chemotaxisGO:00025489.8CALCA, IL6
18cellular response to interleukin-1GO:00713479.8EDN1, IL6
19positive regulation of leukocyte chemotaxisGO:00026909.8CXCL9, IL6
20positive regulation of nitric oxide biosynthetic processGO:00454299.6EDN1, IL6, TNF
21positive regulation of JUN kinase activityGO:00435079.5EDN1, TNF
22positive regulation of smooth muscle cell proliferationGO:00486619.4EDN1, IL6, TNF
23cellular response to tumor necrosis factorGO:00713569.4CALCA, IL6
24immune responseGO:00069559.3CXCL9, IL6, TNF
25cell-cell signalingGO:00072679.1CALCA, CXCL9, EDN1
26cell surface receptor signaling pathwayGO:00071669.0CXCR3, EDN1, TNF
27response to lipopolysaccharideGO:00324968.9CXCL9, EDN1, IL6
28inflammatory responseGO:00069548.8CALCA, CXCL9, IL6, TNF
29positive regulation of transcription from RNA polymerase II promoterGO:00459447.9CXCR3, EDN1, IL6, TNF

Sources for Complex Regional Pain Syndrome Type 1

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet